Literature DB >> 16823541

Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity?

Bernard T Haylen1, Naven Chetty, Vanessa Logan, Serena Schulz, Louise Verity, Matthew Law, Jialun Zhou.   

Abstract

It has been suggested that the urogynecological diagnosis of sensory urgency is an early form of detrusor overactivity and may be just earlier in the spectrum of disease. The former term is generally defined as increased perceived bladder sensation during filling, a low first desire to void and low bladder capacity in the absence of recorded urinary tract infection (UTI) or detrusor overactivity. The aims of this study are to determine the prevalence and associations of sensory urgency in comparison with detrusor overactivity, and whether sensory urgency is shown to be in the same spectrum of bladder dysfunction as detrusor overactivity. Five hundred and ninety-two women attending for an initial urogynecological/urodynamic assessment took part in this prospective study. In addition to a full clinical assessment, all women underwent free uroflowmetry, residual urine volume measurement (by vaginal ultrasound) and multichannel filling and voiding cystometry. Data were separated into those having (1) sensory urgency or (2) detrusor overactivity. Apart from prevalence figures, comparative associations were sought for (3) age; (4) parity; (5) presenting symptoms; (6) presence of at least one (medically) documented UTI in the previous 12 months; (7) two or more (recurrent) documented UTIs in the previous 12 months; (8) prior hysterectomy; (9) prior continence surgery; (10) menopause; (11) menopause and HRT use; (12) sign of clinical stress leakage; (13) retroverted uterus; (14) anterior vaginal wall prolapse; (15) uterine prolapse; (16) posterior vaginal wall prolapse; (17) apical vaginal prolapse; (18, 19) maximum, average urine flow rate (MUFR, AUFR) centiles, Liverpool Nomograms; (20) median residual urine volume (RUV) in milliliters; (21, 22) voiding difficulty: VD1,VD2 (MUFR, AUFR under 10th centile Liverpool Nomogram and/or RUV >30 ml); (23) diagnosis of urodynamic stress incontinence and (24) diagnosis of uterine and/or vaginal prolapse (grade >0). The prevalence of sensory urgency was 13%. The only differences in the clinical and urodynamic profiles of it and detrusor overactivity were (1) significantly increased prevalence of the symptom of urge incontinence and (2) (by definition) abnormal detrusor contractions during filling cystometry in women with detrusor overactivity. Overall, sensory urgency and detrusor overactivity appear to be part of the same spectrum of bladder dysfunction.

Entities:  

Mesh:

Year:  2006        PMID: 16823541     DOI: 10.1007/s00192-006-0165-z

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  59 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Maximal electrical stimulation of patients with frequency, urgency and urge incontinence. Report of 38 cases.

Authors:  M Zöllner-Nielsen; S M Samuelsson
Journal:  Acta Obstet Gynecol Scand       Date:  1992-12       Impact factor: 3.636

3.  The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis.

Authors:  C L Parsons; M Greenberger; L Gabal; M Bidair; G Barme
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

4.  The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology.

Authors:  P Abrams; J G Blaivas; S L Stanton; J T Andersen
Journal:  Scand J Urol Nephrol Suppl       Date:  1988

5.  Sensory urgency in females: treatment with phenylpropanolamine.

Authors:  E Fossberg; H O Beisland; S Sander
Journal:  Eur Urol       Date:  1981       Impact factor: 20.096

Review 6.  An evaluation of the efficacy of in-patient bladder retraining.

Authors:  J A Davies; G Hosker; J Lord; A R Smith
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2000

7.  The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results.

Authors:  L Wiart; P A Joseph; H Petit; J P Dosque; M de Sèze; B Brochet; C Deminière; J M Ferrière; J M Mazaux; P N'Guyen; M Barat
Journal:  Spinal Cord       Date:  1998-02       Impact factor: 2.772

8.  The open bladder neck: a significant finding?

Authors:  G Alessandro Digesu; Vik Khullar; Linda Cardozo; Stefano Salvatore
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-06-05

9.  Nitric oxide: a useful gas in the detection of lower urinary tract inflammation.

Authors:  I Ehrén; A Hosseini; J O Lundberg; N P Wiklund
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

10.  The effect of cholinergic enhancement during filling cystometry: can edrophonium chloride be used as a provocative test for overactive bladder?

Authors:  O Yossepowitch; G Gillon; J Baniel; D Engelstein; P M Livne
Journal:  J Urol       Date:  2001-05       Impact factor: 7.450

View more
  16 in total

1.  International Continence Society 2002 terminology report: have urogynecological conditions (diagnoses) been overlooked?

Authors:  Bernard T Haylen; Naven Chetty
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-09-05

2.  Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction.

Authors:  Bernard T Haylen; Joseph Lee; Sue Husselbee; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-17

3.  Brain activity underlying impaired continence control in older women with overactive bladder.

Authors:  Stasa D Tadic; Derek Griffiths; Werner Schaefer; Andrew Murrin; Becky Clarkson; Neil M Resnick
Journal:  Neurourol Urodyn       Date:  2012-03-30       Impact factor: 2.696

4.  Prevalence of "low-count" bacteriuria in female urinary incontinence versus continent female controls: a cross-sectional study.

Authors:  Colin A Walsh; Anne Siddins; Katrina Parkin; Chinmoy Mukerjee; Kate H Moore
Journal:  Int Urogynecol J       Date:  2011-07-28       Impact factor: 2.894

5.  Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity.

Authors:  Michael L Guralnick; Gwen Grimsby; Michael Liss; Aniko Szabo; R Corey O'Connor
Journal:  Int Urogynecol J       Date:  2009-11-12       Impact factor: 2.894

6.  Does the presenting bladder volume at urodynamics have any diagnostic relevance?

Authors:  Bernard T Haylen; Vivian Yang; Vanessa Logan; Sue Husselbee; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-12-04

Review 7.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

8.  How frequent are overactive bladder symptoms in women with urodynamic verification of an overactive bladder?

Authors:  Ahmet Özgür Yeniel; Mete Ahmet Ergenoğlu; Reci Meseri; Niyazi Aşkar; Ismail Mete Itil
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-06-01

9.  Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity.

Authors:  Seong Jin Jeong; Sang Cheol Lee; Chang Wook Jeong; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  Int Urogynecol J       Date:  2012-05-16       Impact factor: 2.894

10.  Improving the clinical prediction of detrusor overactivity by utilizing additional symptoms and signs to overactive bladder symptoms alone.

Authors:  Bernard T Haylen; Tin Lok Chiu; Dianne Avery; Jialun Zhou; Matthew Law
Journal:  Int Urogynecol J       Date:  2014-03-25       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.